Abstract
Inherited hypokalaemic alkalosis with low blood pressure can be divided into two groups — Gitelman's syndrome, featuring hypocalciuria, hypomagnesaemia and milder clinical manifestations, and Bartter's syndrome, featuring hypercalciuria and early presentation with severe volume depletion. Mutations in the renal Na–Cl cotransporter have been shown to cause Gitelman's syndrome. We demonstrate linkage of Bartter's syndrome to the renal Na–K–2Cl cotransporter gene NKCC2, and identify frameshift or non–conservative missense mutations for this gene that co–segregate with the disease. These findings demonstrate the molecular basis of Bartter's syndrome, provide the basis for molecular classification of patients with inherited hypokalaemic alkalosis, and suggest potential phenotypes in heterozygous carriers of NKCC2 mutations.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lifton, R.R. et al. A chimaeric 11 beta-hydroxylase/aldosterane synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355, 262–265 (1992).
Shimkets, R.A. et al. Liddle's syndrome: heritable human hypertension caused by mutations in the β-subunit of the epithelial sodium channel. Cell 79, 407–414 (1994).
Hansson, J.H. et al. Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle's syndrome. Nature Genet. 11, 76–82 (1995).
Chang, S.S. et al. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypo-aldosteronism type 1. Nature Genet. 12, 248–253 (1996).
Mune, T. et al. Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase. Nature Genet. 10, 394–399 (1995).
Bartter, E.C. et al. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalaemic alkalosis. A new syndrome. Am. J. Med. 33, 811–628 (1962).
Goodman, A.D., Vagnucci, A.H. & Hartroft, P.M. Pathogenesis of Bartter's syndrome. N. Eng. J. Med. 281, 1435–1439 (1969).
Dunn, M.J Prostaglandins and Bartter's syndrome. Kidney Int. 18, 86–102 (1981).
Silverberg, A.B., Mennes, P.A. & Cryer, R.E. Resistance to endogenous norepinephrine in Bartter's syndrome. Reversion during indomethacin administration. Am. J. Med. 64, 231–235 (1978).
Bettinelli, A. et al. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalaemic alkalosis: Bartter and Gitelman syndromes. J. Pediatr. 120, 38–43 (1992).
Hetzel, W. & Molitor, H., Paresen, schmerzsyndrome, bewubtseinsstorrungen: zum neurologischen erscheinungsbild des Bartter-Syndroms. Nevenarzt 62, 500–505 (1991).
Iwata, R., Hanawa, Y. & Takashima, H. Chronic hypomagnesemia and hypokalemia due to renal salt wasting in siblings. Acta Paed. Japonica. 35, 252–257 (1993).
Marco-Franco, J.E. et al. Long-term evolution and growth patterns in a family with Bartter's syndrome. Clin. Nephrol. 42, 33–37 (1994).
Zarraga Larrondo, S. et al. Familial hypokalemia-hypomagnesemia or Gitelman's syndrome: a further case. Nephron 62, 340–344 (1992).
Smilde, T.J. et al. Familial hypokalemia/hypomagnesemia and chondrocalcinosis. J. Rheumatol. 21, 1515–1519 (1994).
Simopoulos, A.R. Growth characteristics in patients with Bartter's syndrome. Nephron 23, 130–135 (1979).
Clive, D.M. Bartter's syndrome: the unsolved puzzle. Am. J. Kid. Dis. 25, 813–823 (1995).
Gitelman, H.J., Graham, J.B. & Welt, L.G. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans. Assoc. Am. Phys. 79, 221–235 (1966).
McCredie, D.A., Rotenberg, E. & Williams, A.L. Hypercalciuria in potassium-losing nephropathy: a variant of Bartter's syndrome. Aust. Paediat J. 10, 286–295 (1974).
Matsumoto, J. et al. Hypercalciuric Bartter syndrome: resolution of nephrocalcinosis with indomethacin. Am. J. Roentgen. 152, 1251–1253 (1989).
Ohlsson, A. et al. A variant of Bartter's syndrome. Bartter's syndrome associated with hydramnios, prematurity, hypercalciuria and nephrocalcinosis. Acta Paed. Scand. 73, 868–874 (1985).
Bianchetti, M.G. et al. Calciuria in Bartter's and similar syndromes. Clin. Nephrol. 38, 338(1992).
Simon, D.B. et al. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-CI cotransporter. Nature Genet. 12, 24–30 (1996).
Gill, J.R. & Bartter, F.C. Evidence for a prostaglandin-independent defect in chloride reabsorption in the loop of Henle as a proximal cause of Bartter's syndrome. Am. J. Med. 65, 766–772 (1978).
Greger, R. Ion transport mechanisms in thick ascending limb of Henle's loop of mammalian nephron. Physiol. Rev. 65, 760–797 (1985).
Greger, R. & Schlatter, E. Cellular mechanism of the action of loop diuretics on the thick ascending limb of Henle's loop. Klin. Woschenschr. 61, 1019–1027 (1991).
Gamba, G. et al. Molecular cloning, primary structure and characterization of two members of the mammalian electroneutral sodium-(potassium)-chloride cotransporter family expressed in kidney. J. Biol. Chem. 26, 17713–17722 (1994).
Payne, J.A. & Forbush, B. Alternatively spliced isoforms of the putative renal Na-K-CI cotransporter are differentially distributed within the rabbit kidney. Proc. Natl. Acad. Sci. USA 91, 4544–4548 (1994).
Igarashi, R et al. Cloning, embryonic expression and alternative splicing of a murine kidney-specific Na-K-CI cotransporter. Am. J. Physiol. 269, F405–F418 (1995).
Xu, J.-C. et al. Molecular cloning and functional expression of the bumetanide-sensitive Na-K-CI cotransporter. Proc. Natl. Acad. Sci. USA 91, 2201–2205 (1994).
Payne, J.A. et al. Primary structure, functional expression, and chromosomal localization of the bumetanide-sensitive Na-K-CI cotransporter in human colon. J. Biol. Chem. 270, 17977–17985 (1995).
Di Pietro, A. et al. La terapia con indometacina interferisce con I'accrescimento nella sindrome di Bartter dell'infanzia? Pediat. Med. Chir. 13, 279–280 (1991).
Lander, E.S. & Botstein, D. Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children. Science 236, 1567–1570 (1987).
Orita, M. et al. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA 86, 2766–2770 (1989).
loannou, PA et al. A new bacteriophage P1-derived vector for the propagation of large human DNA fragments. Nature Genet. 6, 84–89 (1994).
Quaggin, S.E., Payne, J.A.,, Forbush, B. & Igarashi, P. Localization of the renal Na-K-2CI cotransporter gene (Slc12a1) on mouse chromosome 2. Mamm. Genome 6, 557–561 (1995).
Sutton, RAR & Dirks, J.J. Renal handling of calcium, phosphate and magnesium. In The Kidney (eds Brenner, B.M. * Rector, F.C.) 551–618 (Saunders, Philadelphia, 1981).
Seyberth, H.W. et al. Role of prostaglandins in hyperprostaglandin E syndrome and in selected renal tubular disorders. Pediat. Nephrol. 1, 491–497 (1987).
Gill, J.R. et al. Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis. Am. J. Med. 61, 43–51 (1976).
Gullner, H.-G., Gill, J.R. & Bartter, F.C. Correction of hypokalaemia by magnesium repletion in familial hypokalaemic alkalosis with tubulopathy. Am. J. Med. 71, 578–582 (1981).
Gladziwa, U. et al. Chronic hypokalemia of adults: Gitelman's syndrome is frequent but classical Bartter's syndrome is rare. Nepmol. Dial. Transplant. 10, 1607–1613 (1995).
Cooper, D.N. & Krawczak, M. Cytosine methylation and the fate of CpG dinucleotides in vertebrate genomes. Hum. Genet. 83, 181–188 (1989).
Lloyd, S.E. et al. A common molecular basis for three inherited kidney stone-diseases. Nature 379, 445–449 (1996).
Bell, G., Karam, J. & Rutter, W. Polymorphic DNA region adjacent to the 5- end of the human insulin gene. Proc. Natl. Acad. Sci. USA 78, 5759–5763 (1981).
Gyapay, G. et al. The 1993–94 Genethon human genetic linkage map. Nature Genet. 7, 246–339 (1994).
Lathrop, G.M. et al. Strategies for multilocus linkage in humans. Proc. Natl. Acad. Sci. USA 81, 3443–3446 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Simon, D., Karet, F., Hamdan, J. et al. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na–K–2CI cotransporter NKCC2. Nat Genet 13, 183–188 (1996). https://doi.org/10.1038/ng0696-183
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0696-183
This article is cited by
-
Integrative genome-wide analyses identify novel loci associated with kidney stones and provide insights into its genetic architecture
Nature Communications (2023)
-
A novel mutation of KCNJ1 identified in an affected child with nephrolithiasis
BMC Nephrology (2022)
-
The genetics of kidney stone disease and nephrocalcinosis
Nature Reviews Nephrology (2022)
-
Pathophysiological aspects of the thick ascending limb and novel genetic defects: HELIX syndrome and transient antenatal Bartter syndrome
Pediatric Nephrology (2022)
-
Crown ether-thiourea conjugates as ion transporters
Frontiers of Chemical Science and Engineering (2022)